BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


Gain in-depth analysis on the avian flu market and future of the antivirals market as a whole

Gain in-depth analysis on the avian flu market and future of the antivirals market as a whole, product pipelines and major players with Business Insights’ latest antivirals report...

The Tamiflu drug is one of the four antiviral drugs used for the treatment of influenza drugs, profiled in our latest antivirals report titled: The Antivirals Market Outlook: Market analysis of future growth and leading players by sector. This report examines the diagnosis, treatment and patient potential for the influenza therapy and analyzes the key players in this market.

For each market therapy area detailed in this report (HIV, Hepatitis, Herpes, RSV, Influenza and HPV), there is a country-by-country analysis, a review of the top companies and an analysis of key brands. The report identifies unmet needs and growth opportunities in each market, reviewing some of the high money earners in the R&D pipeline.

FREE report offer

Purchase 'The Antivirals Market Outlook' and receive ‘The Vaccines Market Outlook’ FREE of charge when you place your order before October 31st 2005.

Both the reports listed above will help you to gain in-depth insight into the future of the antivirals and vaccines market by reviewing...

* Expert analysis of all major antiviral and vaccine drugs, using gold standard IMS Health data

* A breakdown of the antivirals and vaccines market by key therapy areas, brands and companies

* An assessment of the unmet needs in each therapy area

 

The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.
Report Description:

 

Business Insights have teamed up with IMS Health to bring you, ‘The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, an unrivalled source of pharmaceutical intelligence on the Antivirals market. 'The Antivirals Market Outlook: Market analysis of future growth and leading players by sector', analyzes the market development in the US and the five major European markets. The major therapy areas covered in this report are: HIV, hepatitis, herpes, influenza, RSV and HPV. For each market therapy area there is a country-by-country analysis, a review of leading companies and an analysis of key brands allowing you to assess the best pipeline areas to invest in. Identify unmet needs and growth opportunities in each market by reviewing pipeline drugs with the most potential for profit for your company. Published: January 2005

 

http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_Business_Insight_2004.html#a976

 

The Vaccines Market Outlook: Market analysis of future growth and leading players by sector.

Report Description:

 

Business Insights have teamed up with IMS Health to bring you, ‘The Vaccines Market Outlook: Market analysis of future growth and leading players by sector.’ This unique report provides unrivalled analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, and also includes company reported sales data allowing you to spot any discrepancies between the two sets of data. Refresh your vaccines strategy with unrivalled analysis The Vaccines Market Outlook: Market analysis of future growth and leading players by sector provides a detailed analysis of the vaccines market in the US and the five major European markets. The market for vaccines is broken down by population (pediatric and adult) and also by disease area. A comprehensive competitive overview is provided with an examination of key brands together with profiles of the leading players in this market. This new report also reviews some of the most promising products in development, highlighting those expected to drive market growth in the future and in some cases become the first vaccine to market for a disease. Adult and travel vaccine segments are likely to drive growth in the future, use this latest vaccines report to discover the latest products which are set to transform this market. Published January 2005

 

http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_Business_Insight_2004.html#a978


To order these reports contact peter.barfoot@bioportfolio.com or telephone +44 1300 321501 or +1 415 680 2472 and a representative will get back to you.

You can also order on line at: http://www.bioportfolio.com/cgi-bin/acatalog/search.html 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.